TAM_MYXSM
ID TAM_MYXSM Reviewed; 526 AA.
AC B8ZV94;
DT 03-MAY-2011, integrated into UniProtKB/Swiss-Prot.
DT 03-MAR-2009, sequence version 1.
DT 03-AUG-2022, entry version 36.
DE RecName: Full=Tyrosine 2,3-aminomutase {ECO:0000303|PubMed:19222035};
DE Short=MxTAM {ECO:0000303|PubMed:19222035};
DE EC=5.4.3.6;
DE AltName: Full=Tyrosine ammonia-lyase {ECO:0000303|PubMed:19222035};
DE EC=4.3.1.23;
GN Name=tam {ECO:0000312|EMBL:CAR79034.1};
OS Myxococcus sp. (strain Mx-B0).
OC Bacteria; Proteobacteria; Deltaproteobacteria; Myxococcales;
OC Cystobacterineae; Myxococcaceae; Myxococcus; unclassified Myxococcus.
OX NCBI_TaxID=563923;
RN [1] {ECO:0000305, ECO:0000312|EMBL:CAR79034.1}
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND CATALYTIC ACTIVITY.
RX PubMed=19222035; DOI=10.1002/cbic.200800748;
RA Krug D., Muller R.;
RT "Discovery of additional members of the tyrosine aminomutase enzyme family
RT and the mutational analysis of CmdF.";
RL ChemBioChem 10:741-750(2009).
CC -!- FUNCTION: Has aminomutase and, to a much lesser extent, ammonia-lyase
CC activity. Primarily, catalyzes the rearrangement of L-tyrosine to S-
CC beta-tyrosine, which is probably incorporated into secondary metabolite
CC myxovalargin. The aminomutase activity exclusively produces S-beta-
CC tyrosine. {ECO:0000269|PubMed:19222035}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=L-tyrosine = 3-amino-3-(4-hydroxyphenyl)propanoate;
CC Xref=Rhea:RHEA:15781, ChEBI:CHEBI:57956, ChEBI:CHEBI:58315;
CC EC=5.4.3.6; Evidence={ECO:0000269|PubMed:19222035};
CC -!- CATALYTIC ACTIVITY:
CC Reaction=L-tyrosine = (E)-4-coumarate + NH4(+); Xref=Rhea:RHEA:24906,
CC ChEBI:CHEBI:12876, ChEBI:CHEBI:28938, ChEBI:CHEBI:58315; EC=4.3.1.23;
CC Evidence={ECO:0000269|PubMed:19222035};
CC -!- SUBUNIT: Homotetramer; dimer of dimers. {ECO:0000250}.
CC -!- PTM: Contains an active site 4-methylidene-imidazol-5-one (MIO), which
CC is formed autocatalytically by cyclization and dehydration of residues
CC Ala-Ser-Gly. {ECO:0000250|UniProtKB:P21310}.
CC -!- SIMILARITY: Belongs to the TAL/TAM family.
CC {ECO:0000269|PubMed:19222035}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; FM212244; CAR79034.1; -; Genomic_DNA.
DR AlphaFoldDB; B8ZV94; -.
DR SMR; B8ZV94; -.
DR BRENDA; 5.4.3.6; 11881.
DR GO; GO:0016841; F:ammonia-lyase activity; IDA:UniProtKB.
DR GO; GO:0050368; F:tyrosine 2,3-aminomutase activity; IDA:UniProtKB.
DR GO; GO:0052883; F:tyrosine ammonia-lyase activity; IEA:UniProtKB-EC.
DR GO; GO:0009403; P:toxin biosynthetic process; IDA:UniProtKB.
DR CDD; cd00332; PAL-HAL; 1.
DR Gene3D; 1.10.275.10; -; 1.
DR InterPro; IPR001106; Aromatic_Lyase.
DR InterPro; IPR024083; Fumarase/histidase_N.
DR InterPro; IPR008948; L-Aspartase-like.
DR InterPro; IPR022313; Phe/His_NH3-lyase_AS.
DR PANTHER; PTHR10362; PTHR10362; 1.
DR Pfam; PF00221; Lyase_aromatic; 1.
DR SUPFAM; SSF48557; SSF48557; 1.
DR PROSITE; PS00488; PAL_HISTIDASE; 1.
PE 1: Evidence at protein level;
KW Isomerase; Lyase.
FT CHAIN 1..526
FT /note="Tyrosine 2,3-aminomutase"
FT /id="PRO_0000407377"
FT ACT_SITE 41
FT /note="Proton donor/acceptor"
FT /evidence="ECO:0000250"
FT BINDING 71
FT /ligand="substrate"
FT /evidence="ECO:0000250"
FT BINDING 183
FT /ligand="substrate"
FT /evidence="ECO:0000250"
FT BINDING 288
FT /ligand="substrate"
FT /evidence="ECO:0000250"
FT MOD_RES 131
FT /note="2,3-didehydroalanine (Ser)"
FT /evidence="ECO:0000250|UniProtKB:P21310,
FT ECO:0000255|PROSITE-ProRule:PRU10122"
FT CROSSLNK 130..132
FT /note="5-imidazolinone (Ala-Gly)"
FT /evidence="ECO:0000250|UniProtKB:P21310"
SQ SEQUENCE 526 AA; 56946 MW; F727BE24953C29FD CRC64;
MDIYAVAVGR VGVELDAAQL ERVRATHLRV QGWGMEKYPM YGVNTGFGEL INVIIPPQFK
SDLQHNLLRS HAAGGGEPFP DEVVRAIMTV RINCLMKGYS GISPEALQLL ATMLNRGIHP
VIPMQGSLGA SGDLAPLSHM ALPLIGDGHV RKNGVTRPTM EVFQEEGLTP LKLGFKEGLA
LVNGTSAMTG AASLALYRAR HLLRLSLLAS ADIVQAMNAS TRPFSHTGNA VKNHPGQVVI
ARLMRDLTEG TGLMRDHQDI MRAISERTSH SNDVEETEIY LQNAYSLRCM PQVLGVVLET
LQMCQRFIEE EANSVNDNPV ILDTPAETYH GANFHGQYVA MACDYLSIAV AEMGVLAERQ
LNRLLDPHIN KPLPGFLAHA KTGLFCGFEG GQYLATSIAS ENLDLAAPSS IKSIPSNGQN
QDIVSMGLIA ARKTLALCEN VGTILSVLMA ALNQASHFTE AAKYSAPIRS IHEKLGKVAP
RYEDERPMST VIAQVRGVLL QEQGLALAQS LVNLDLTPDL SLEPRA